WHA Update: State Of Funding Of The Ebola Response In DRC 28/05/2018 Damilola Adepeju The World Health Organization (WHO) in a report last week released the funding situation regarding the response to the Ebola outbreak in the Democratic Republic of Congo (DRC). The amount of funding needed for the Ebola Strategic Response Plan has increased to US$56.8 million, WHO said. Continue reading -> Major Study Finds Taxes On Soda, Alcohol, Tobacco Help Curb NCDs; Study Restarts UN Momentum 05/04/2018 William New A major new study published in the The Lancet journal this week restarts discussions in international organisations over how to address non-communicable diseases (NCDs) worldwide. The study found that taxing soft drinks, alcohol and tobacco can lead to significant health gains among the poorest in society. Continue reading -> WHO Names High-Profile Commission On Non-Communicable Diseases 16/02/2018 William New The World Health Organization today announced a new high-level commission of heads of state, ministers and other leaders in health and development to come up with "bold and innovative solutions" against non-communicable diseases such as heart and respiratory diseases, cancers and diabetes. The chairs of the commission include the presidents of Uruguay, Sri Lanka, and Finland, the Russian health minister, and a former minister of Pakistan who was a candidate for director general of the WHO. They are joined by nearly two dozen others, including corporate public figures Michael Bloomberg and Jack Ma. Continue reading -> Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny 08/02/2018 Catherine Saez The unexpected announcement in December of the resignation of the Medicines Patent Pool executive director left the Pool searching for its new head. Marie-Paule Kieny, former World Health Organization assistant director general, now chair of the MPP governance board stepped in to oversee the MPP while the search goes on. She sat down recently for an interview with Intellectual Property Watch to explain that MPP is conducting business as usual, and is keeping firm in its plan to release the results of a feasibility study analysing the possibility for MPP to extend its licensing activities to other essential medicines still under patent. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
Major Study Finds Taxes On Soda, Alcohol, Tobacco Help Curb NCDs; Study Restarts UN Momentum 05/04/2018 William New A major new study published in the The Lancet journal this week restarts discussions in international organisations over how to address non-communicable diseases (NCDs) worldwide. The study found that taxing soft drinks, alcohol and tobacco can lead to significant health gains among the poorest in society. Continue reading -> WHO Names High-Profile Commission On Non-Communicable Diseases 16/02/2018 William New The World Health Organization today announced a new high-level commission of heads of state, ministers and other leaders in health and development to come up with "bold and innovative solutions" against non-communicable diseases such as heart and respiratory diseases, cancers and diabetes. The chairs of the commission include the presidents of Uruguay, Sri Lanka, and Finland, the Russian health minister, and a former minister of Pakistan who was a candidate for director general of the WHO. They are joined by nearly two dozen others, including corporate public figures Michael Bloomberg and Jack Ma. Continue reading -> Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny 08/02/2018 Catherine Saez The unexpected announcement in December of the resignation of the Medicines Patent Pool executive director left the Pool searching for its new head. Marie-Paule Kieny, former World Health Organization assistant director general, now chair of the MPP governance board stepped in to oversee the MPP while the search goes on. She sat down recently for an interview with Intellectual Property Watch to explain that MPP is conducting business as usual, and is keeping firm in its plan to release the results of a feasibility study analysing the possibility for MPP to extend its licensing activities to other essential medicines still under patent. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
WHO Names High-Profile Commission On Non-Communicable Diseases 16/02/2018 William New The World Health Organization today announced a new high-level commission of heads of state, ministers and other leaders in health and development to come up with "bold and innovative solutions" against non-communicable diseases such as heart and respiratory diseases, cancers and diabetes. The chairs of the commission include the presidents of Uruguay, Sri Lanka, and Finland, the Russian health minister, and a former minister of Pakistan who was a candidate for director general of the WHO. They are joined by nearly two dozen others, including corporate public figures Michael Bloomberg and Jack Ma. Continue reading -> Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny 08/02/2018 Catherine Saez The unexpected announcement in December of the resignation of the Medicines Patent Pool executive director left the Pool searching for its new head. Marie-Paule Kieny, former World Health Organization assistant director general, now chair of the MPP governance board stepped in to oversee the MPP while the search goes on. She sat down recently for an interview with Intellectual Property Watch to explain that MPP is conducting business as usual, and is keeping firm in its plan to release the results of a feasibility study analysing the possibility for MPP to extend its licensing activities to other essential medicines still under patent. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny 08/02/2018 Catherine Saez The unexpected announcement in December of the resignation of the Medicines Patent Pool executive director left the Pool searching for its new head. Marie-Paule Kieny, former World Health Organization assistant director general, now chair of the MPP governance board stepped in to oversee the MPP while the search goes on. She sat down recently for an interview with Intellectual Property Watch to explain that MPP is conducting business as usual, and is keeping firm in its plan to release the results of a feasibility study analysing the possibility for MPP to extend its licensing activities to other essential medicines still under patent. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
“We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
New Text Shows Progress Of Negotiation On IP And Access At WHO 25/01/2018 Catherine Saez The Brazilian ambassador and others this morning at the World Health Organization Executive Board meeting were not going to let go of what seemed to be a delaying tactic by the United States and Japan to postpone agreement on the implementation of measures aimed at facilitating research and development and access to medicines. The WHO Board today is considering a set of streamlined strategic measures on public health, innovation, and intellectual property. Continue reading -> WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
WHO Board Shows Resolve In Tackling Shortages, Access To Medicines, Vaccines 25/01/2018 Catherine Saez The members of the World Health Organization Executive Board tonight (24 January) agreed to create a roadmap on global shortages of, and access to, medicines and vaccines. WHO members proclaimed the urgent need to address prices and availability of safe and efficient medicines and vaccines, some requesting the recently elected director general of the organisation to help find solutions. Continue reading -> Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts
Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 Catherine Saez Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices. Continue reading -> Posts navigation Older postsNewer posts